Workers across Brazil now have a legal guarantee to prioritize their health without risking their paychecks. A new law, sanctioned by President Luiz Inácio Lula da Silva and published in the Official Gazette on April 6, 2026, grants employees the right to seize up to three days of paid leave per year specifically for HPV (human papillomavirus) preventive examinations.
The legislation marks a significant shift in Brazilian labor law, expanding existing protections for cancer screenings to explicitly include the tracking of this sexually transmitted infection (STI). By removing the professional penalty for seeking early diagnosis, the government aims to curb a mounting public health crisis where preventable cancers continue to claim thousands of lives annually.
As a physician, I view this as more than just a labor adjustment. it is a critical intervention in the chain of cancer prevention. HPV is the primary driver of several malignancies and the barrier of “work-hour conflict” has long hindered middle- and low-income populations from accessing routine screenings. By institutionalizing this folga para prevenção de HPV, the state is treating preventative care as a fundamental right rather than a luxury of the flexible professional.
Expanding the Safety Net: What the Law Changes
The new regulation introduces specific modifications to the Consolidation of Labor Laws (CLT), the bedrock of employment regulation in Brazil. The law, which originated from Bill 4.968/2020, targets two primary areas of the code to ensure both employee access and employer accountability.
First, it modifies Article 473, which previously regulated paid absences for cancer prevention exams. The updated text now explicitly includes HPV screening, ensuring that the time taken for these tests is not deducted from the worker’s salary. Second, the law inserts Article 169-A, which transforms the role of the employer from a passive observer to an active participant in public health.
Under Article 169-A, companies are now legally obligated to inform their staff about official vaccination campaigns and provide educational material on HPV, as well as breast, prostate, and cervical cancers. This mandate aligns corporate environments with the recommendations of the Ministério da Saúde, requiring employers to guide workers on how to access diagnostic services within the public and private health systems.
| Legal Provision | Previous Status | New Requirement (2026) |
|---|---|---|
| Article 473 | Paid leave for general cancer screenings. | Explicit inclusion of HPV preventive exams (up to 3 days/year). |
| Article 169-A | No specific disclosure mandate. | Obligatory company communication on vaccinations and cancer risks. |
The Clinical Urgency: Why HPV Screening Matters
The push for this legislation is grounded in sobering statistics. HPV is a pervasive virus that affects nearly all sexually active individuals at some point in their lives. While many infections are cleared by the immune system, persistent high-risk strains can lead to cellular changes that evolve into cancer. While most commonly associated with the cervix, HPV is also linked to cancers of the vulva, vagina, penis, anus, and the oropharynx (the back of the throat).
The human cost in Brazil is stark. According to data from the Ministry of Health, cervical cancer—which is caused almost exclusively by HPV—claimed the lives of approximately 20 women per day in 2025. This is a tragedy of prevention; cervical cancer is highly treatable, and often curable, if detected in the precancerous stage through regular Pap smears or HPV DNA tests.
It is also vital to dismantle the myth that HPV is solely a “woman’s issue.” Men are not only carriers but are also susceptible to HPV-related malignancies. The inclusion of men in the three-day leave provision acknowledges the role of male screening and vaccination in breaking the cycle of transmission and protecting overall population health.
The Broader Cancer Landscape in Brazil
The HPV law arrives at a time when Brazil is facing a surge in oncological cases. The Instituto Nacional de Câncer (INCA) estimates that the country will record 781,000 new cancer cases annually between 2026 and 2028. This puts immense pressure on the Unified Health System (SUS) and underscores the necessity of early detection.
- Women’s Health: Breast cancer remains the most prevalent tumor among women, accounting for 30% of all female cancer cases.
- Men’s Health: Prostate cancer continues to be the most incident tumor among the male population.
- The HPV Link: Unlike breast or prostate cancer, which have complex genetic and environmental drivers, HPV-related cancers have a clear, preventable cause: the virus itself.
Impact on the Workforce and Next Steps
For the average worker, the implementation of this law means a reduction in the “health guilt” often associated with taking time off. For the employer, it requires a transition toward a culture of corporate wellness. The requirement to promote awareness campaigns means that the workplace becomes a primary point of contact for health literacy, potentially increasing the uptake of the HPV vaccine, which is available for free via the SUS for specific age groups.
However, the success of this law depends on the rigor of its enforcement. Workers are encouraged to keep documented proof of their medical appointments to ensure the leave is recognized under the modified Article 473. Simultaneously, labor unions and health advocates are expected to monitor whether companies are fulfilling their disclosure obligations under Article 169-A.
Disclaimer: This article is for informational purposes only and does not constitute legal or medical advice. Please consult a healthcare provider for screening recommendations and a legal professional regarding labor rights.
The next critical checkpoint for this policy will be the first annual review of health screenings by the Ministry of Health in late 2026, which will likely analyze whether the removal of work-related barriers has led to a measurable increase in early HPV detection rates across different socioeconomic strata.
We want to hear from you. Do you think these health-focused labor laws should be expanded to other chronic conditions? Share your thoughts in the comments below.
Related reading
